Literature DB >> 24574239

Drug-associated polymyalgia rheumatica/giant cell arteritis occurring in two patients after treatment with ipilimumab, an antagonist of ctla-4.

Barbara L Goldstein1, Lydia Gedmintas, Derrick J Todd.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24574239     DOI: 10.1002/art.38282

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  60 in total

1.  A paraneoplastic syndrome exacerbated by checkpoint inhibition therapy.

Authors:  Heather Villarreal; Kathryn H Dao
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-10-12

Review 2.  Immune checkpoint dysfunction in large and medium vessel vasculitis.

Authors:  Ryu Watanabe; Hui Zhang; Gerald Berry; Jörg J Goronzy; Cornelia M Weyand
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-17       Impact factor: 4.733

Review 3.  Checkpoint Inhibitors.

Authors:  Lucie Heinzerling; Enrico N de Toni; Georg Schett; Gheorghe Hundorfean; Lisa Zimmer
Journal:  Dtsch Arztebl Int       Date:  2019-02-22       Impact factor: 5.594

Review 4.  Cardiovascular toxicities associated with immune checkpoint inhibitors.

Authors:  Jiun-Ruey Hu; Roberta Florido; Evan J Lipson; Jarushka Naidoo; Reza Ardehali; Carlo G Tocchetti; Alexander R Lyon; Robert F Padera; Douglas B Johnson; Javid Moslehi
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

Review 5.  Systemic Vasculitis Associated With Immune Check Point Inhibition: Analysis and Review.

Authors:  Teresa M Crout; Day S Lennep; Shweta Kishore; Vikas Majithia
Journal:  Curr Rheumatol Rep       Date:  2019-05-21       Impact factor: 4.592

Review 6.  The relationships between cancer and autoimmune rheumatic diseases.

Authors:  Laura C Cappelli; Ami A Shah
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-02-03       Impact factor: 4.098

7.  Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab.

Authors:  Laura C Cappelli; Anna Kristina Gutierrez; Alan N Baer; Jemima Albayda; Rebecca L Manno; Uzma Haque; Evan J Lipson; Karen B Bleich; Ami A Shah; Jarushka Naidoo; Julie R Brahmer; Dung Le; Clifton O Bingham
Journal:  Ann Rheum Dis       Date:  2016-06-15       Impact factor: 19.103

8.  Diagnosis and Management of Rare Immune-Related Adverse Events.

Authors:  Sara R Schoenfeld; Mary E Aronow; Rebecca Karp Leaf; Michael Dougan; Kerry L Reynolds
Journal:  Oncologist       Date:  2019-11-06

Review 9.  Immune-Related Adverse Effects of Cancer Immunotherapy- Implications for Rheumatology.

Authors:  Laura C Cappelli; Ami A Shah; Clifton O Bingham
Journal:  Rheum Dis Clin North Am       Date:  2016-10-22       Impact factor: 2.670

Review 10.  Immune checkpoint inhibitor-induced musculoskeletal manifestations.

Authors:  Foteini Angelopoulou; Dimitrios Bogdanos; Theodoros Dimitroulas; Lazaros Sakkas; Dimitrios Daoussis
Journal:  Rheumatol Int       Date:  2020-08-02       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.